BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9847053)

  • 21. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.
    Heinricher MM; McGaraughty S; Grandy DK
    J Neurophysiol; 1997 Dec; 78(6):3351-8. PubMed ID: 9405549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of NOC/oFQ in impaired opioid-induced pial artery dilation following brain injury.
    Armstead WM
    Brain Res; 2000 Jun; 869(1-2):231-5. PubMed ID: 10865080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.
    Berger H; Albrecht E; Wallukat G; Bienert M
    Br J Pharmacol; 1999 Feb; 126(3):555-8. PubMed ID: 10188961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.
    Jenck F; Moreau JL; Martin JR; Kilpatrick GJ; Reinscheid RK; Monsma FJ; Nothacker HP; Civelli O
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14854-8. PubMed ID: 9405703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice.
    Reinscheid RK; Nothacker H; Civelli O
    Peptides; 2000 Jul; 21(7):901-6. PubMed ID: 10998523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis.
    Kato S; Tsuzuki Y; Hokari R; Okada Y; Miyazaki J; Matsuzaki K; Iwai A; Kawaguchi A; Nagao S; Itoh K; Suzuki H; Nabeshima T; Miura S
    J Neuroimmunol; 2005 Apr; 161(1-2):21-8. PubMed ID: 15748940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociceptin/orphanin FQ contributes to hypoxic/ischemic impairment of hypercapnic cerebrovasodilation.
    Jagolino A; Armstead WM
    Brain Res Bull; 2001 Jul; 55(4):465-8. PubMed ID: 11543945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
    Wang JL; Zhu CB; Cao XD; Wu GC
    Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic localization of (125)I[Tyr(14)]orphanin FQ/nociceptin and (125)I[Tyr(10)]orphanin FQ/nociceptin(1-11) binding sites in rat brain.
    Letchworth SR; Mathis JP; Rossi GC; Bodnar RJ; Pasternak GW
    J Comp Neurol; 2000 Jul; 423(2):319-29. PubMed ID: 10867661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between nociceptin/orphanin FQ and cerebral hemodynamics after hypoxia-ischemia in piglets.
    Armstead WM
    Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H477-83. PubMed ID: 10666078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury.
    Kulkarni M; Armstead WM
    J Neurotrauma; 2002 Aug; 19(8):965-73. PubMed ID: 12225656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-Dependent vasopressinergic modulation of Noc/oFQ-induced impairment of NMDA cerebrovasodilation after brain injury.
    Armstead WM
    J Neurotrauma; 2001 Jun; 18(6):615-23. PubMed ID: 11437084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orphanin FQ/nociceptin analgesia in the rat.
    Rossi GC; Perlmutter M; Leventhal L; Talatti A; Pasternak GW
    Brain Res; 1998 May; 792(2):327-30. PubMed ID: 9593974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered release of prostaglandins contributes to hypoxic/ischemic impairment of NOC/oFQ cerebrovasodilation.
    Armstead WM
    Brain Res; 2000 Mar; 859(1):104-12. PubMed ID: 10720619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nociceptin/orphanin FQ on feeding behavior and hypothalamic neuropeptide expression in layer-type chicks.
    Bungo T; Shiraishi J; Yanagita K; Ohta Y; Fujita M
    Gen Comp Endocrinol; 2009 Sep; 163(1-2):47-51. PubMed ID: 19318106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
    Rossi GC; Leventhal L; Bolan E; Pasternak GW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age dependent endothelin contribution to NOC/oFQ induced impairment of NMDA cerebrovasodilation after brain injury.
    Armstead WM
    Peptides; 2001 Jan; 22(1):39-46. PubMed ID: 11179596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection.
    Suaudeau C; Florin S; Meunier JC; Costentin J
    Fundam Clin Pharmacol; 1998; 12(4):420-5. PubMed ID: 9711464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOC/oFQ activates ERK and JNK but not p38 MAPK to impair prostaglandin cerebrovasodilation after brain injury.
    Ross J; Armstead WM
    Brain Res; 2005 Aug; 1054(1):95-102. PubMed ID: 16099438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between nociceptin/orphanin FQ (N/OFQ) and GABA in response to feeding.
    Tajalli S; Jonaidi H; Abbasnejad M; Denbow DM
    Physiol Behav; 2006 Oct; 89(3):410-3. PubMed ID: 16904711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.